ID22660A - Turunan-turunan piridina dan komposisi farmasi yang mengandungnya - Google Patents

Turunan-turunan piridina dan komposisi farmasi yang mengandungnya

Info

Publication number
ID22660A
ID22660A IDW991080A ID991080A ID22660A ID 22660 A ID22660 A ID 22660A ID W991080 A IDW991080 A ID W991080A ID 991080 A ID991080 A ID 991080A ID 22660 A ID22660 A ID 22660A
Authority
ID
Indonesia
Prior art keywords
pyridine
decreases
composition containing
pharmacy composition
pharmacy
Prior art date
Application number
IDW991080A
Other languages
English (en)
Inventor
David Cheshire
David Cladingboel
Simon Hirst
Carol Manners
Michael Stocks
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9701100A external-priority patent/SE9701100D0/xx
Priority claimed from SE9702199A external-priority patent/SE9702199D0/xx
Priority claimed from SE9704403A external-priority patent/SE9704403D0/xx
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Publication of ID22660A publication Critical patent/ID22660A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IDW991080A 1997-03-25 1998-03-20 Turunan-turunan piridina dan komposisi farmasi yang mengandungnya ID22660A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9701100A SE9701100D0 (sv) 1997-03-25 1997-03-25 Novel compounds
SE9702199A SE9702199D0 (sv) 1997-06-09 1997-06-09 Novel compounds
SE9704403A SE9704403D0 (sv) 1997-11-28 1997-11-28 Novel compounds

Publications (1)

Publication Number Publication Date
ID22660A true ID22660A (id) 1999-12-02

Family

ID=27355863

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991080A ID22660A (id) 1997-03-25 1998-03-20 Turunan-turunan piridina dan komposisi farmasi yang mengandungnya

Country Status (17)

Country Link
US (1) US6300352B1 (id)
EP (1) EP0971892A1 (id)
JP (1) JP2001518115A (id)
KR (1) KR20010005646A (id)
CN (1) CN1257481A (id)
AR (1) AR012157A1 (id)
AU (1) AU6530998A (id)
BR (1) BR9808042A (id)
CA (1) CA2284200A1 (id)
EE (1) EE9900426A (id)
ID (1) ID22660A (id)
IL (1) IL131846A0 (id)
NO (1) NO994659L (id)
PL (1) PL335905A1 (id)
SK (1) SK130599A3 (id)
TR (1) TR199902350T2 (id)
WO (1) WO1998042670A1 (id)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521618B2 (en) 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
US6376524B1 (en) 2000-06-21 2002-04-23 Sunesis Pharmaceuticals, Inc. Triphenyl compounds as interleukin-4 antagonists
US7335779B2 (en) * 2002-03-08 2008-02-26 Quonova, Llc Modulation of pathogenicity
US7338969B2 (en) * 2002-03-08 2008-03-04 Quonova, Llc Modulation of pathogenicity
PL376751A1 (pl) * 2002-11-12 2006-01-09 Abbott Laboratories Bicykliczne podstawione aminy jako ligandy receptora histaminowego-3
US7153889B2 (en) * 2002-11-12 2006-12-26 Abbott Laboratories Bicyclic-substituted amines as histamine-3 receptor ligands
US20040092521A1 (en) * 2002-11-12 2004-05-13 Altenbach Robert J. Bicyclic-substituted amines as histamine-3 receptor ligands
US20070196340A1 (en) * 2003-05-06 2007-08-23 Aldo Ammendola Modulation of Pathogenicity
US20070265345A1 (en) * 2004-07-27 2007-11-15 Smithkline Beecham Corporation Novel Biphenyl Compounds And Their Use
US7498049B1 (en) * 2007-01-03 2009-03-03 Shmuel Gonen Topical treatment of acne with combined herbal extracts and minerals
MX389242B (es) 2015-06-15 2025-03-20 Nmd Pharma As Compuestos para su uso en el tratamiento de trastornos neuromusculares
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US12440477B2 (en) 2017-12-14 2025-10-14 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
CN113692304B (zh) * 2019-02-06 2025-03-18 礼来公司 作为kcnq增强剂的1-((2-(2,2,2-三氟乙氧基)吡啶-4-基)甲基)脲衍生物
CN114989114A (zh) * 2022-06-02 2022-09-02 杭州福斯特电子材料有限公司 一种n-丙烯酰吗啉的合成方法及光固化组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0267439A3 (en) * 1986-10-14 1988-08-31 G.D. Searle & Co. Alpha-(phenylalkyl) pyridinealkanol derivatives
EP0264114A1 (en) * 1986-10-16 1988-04-20 G.D. Searle & Co. Alpha-[(phenylmethoxy)methyl]pyridine-alkanol derivatives
NZ323521A (en) * 1995-12-06 1999-10-28 Astra Pharma Prod Compounds for treating reversible obstructive airway disease or allergic conditions

Also Published As

Publication number Publication date
NO994659D0 (no) 1999-09-24
US6300352B1 (en) 2001-10-09
IL131846A0 (en) 2001-03-19
EE9900426A (et) 2000-04-17
CA2284200A1 (en) 1998-10-01
CN1257481A (zh) 2000-06-21
JP2001518115A (ja) 2001-10-09
BR9808042A (pt) 2000-03-08
KR20010005646A (ko) 2001-01-15
AU6530998A (en) 1998-10-20
EP0971892A1 (en) 2000-01-19
WO1998042670A1 (en) 1998-10-01
AR012157A1 (es) 2000-09-27
NO994659L (no) 1999-11-25
TR199902350T2 (xx) 2000-04-21
SK130599A3 (en) 2000-05-16
PL335905A1 (en) 2000-05-22

Similar Documents

Publication Publication Date Title
ID25543A (id) Alpha-aril-n-alkinitron dan komposisi farmasi yang mengandungnya
ID23439A (id) Turunan-turunan 3-piperidil-4-oksokuinazolin dan komposisi-komposisi farmasi yang sama
ID25528A (id) Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya
ID24148A (id) Turunan-turunan fitostfrol dan/atau fitostanol
FI973475L (fi) Koostumus ja sitä sisältävä tuote
ID22889A (id) Komposisi kopolimer etilena dan penggunaannya
ID23978A (id) Turunan-turunan tienopirimidin dan tienopiridin yang berguna sebagai zat-zat anti kangker
ID23575A (id) Pirazolopirimidina-pirazolopirimidina dan pirazolotriazina-pirazolotriazina
ID24839A (id) Senyawa-senyawa triazol dan penggunaannya
ID29591A (id) Senyawa-senyawa kuinolina dan kuinoksalina
ID21491A (id) Komposisi aerosol farmasi
ID28114A (id) Sitokin mamalia; interleukin-b30 dan pereaksi-pereaksi terkait
ID24929A (id) Turunan 2-aril-8-oksodihidropurin, proses pembuatannya, komposisi farmasinya yang mengandungnya, dan senyawa antaranya
FI974141A7 (fi) Viestin sisällön hyödyntäminen
DE69836513D1 (de) Thermooptische Vorrichtungen
DE69816084D1 (de) Tintenaufnehmende zusammensetzungen sowie damit beschichtete produkte
ID27680A (id) Komposisi poliester, metoda produksi daripadanya dan film poliester
ID24476A (id) Arilsulfonamida dan analognya
ID22957A (id) Senyawa dan penggunaannya
ID27669A (id) Film biodegradabel dan metode pembuatannya
GB9711207D0 (en) Adhesive composition or structure
DE69830372D1 (de) Gaserzeugende zusammensetzung und formmasse davon
ID27667A (id) Komposisi coklat dan pemakaiannya
ID17774A (id) Komposisi farmasi antitrombosis
ID24828A (id) Komposisi-komposisi farmasi dari tizoksianida dan nitazoksanida